echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Tumor Dacu Beijing theory to jointly explore the new development of MDT in China.

    Tumor Dacu Beijing theory to jointly explore the new development of MDT in China.

    • Last Update: 2020-08-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    (Health Times reporter Dong Lanjun) May 18, by the Chinese Physicians Association (CMDA) and Sanofi co-organized the 3rd MDT China Model Summit Forum held in Beijing.
    Vice President of Peking University Cancer Hospital Shen Lin, Director of Gastroenterology Surgery Ye Yingjiang of Peking University People's Hospital as President of the Forum, President of Peking University Cancer Hospital Ji Jiafu, Director of the Medical Resources Department of the National Health and Health Administration, Director of the Medical Resources Department of the National Health and Health Administration, Director of Oncology Medicine Liu Yunpeng, Director of Oncology Department of Zhejiang Medical University, Zhang Suzhang Secretary of the Second Hospital affiliated with Zhejiang University Medical College, Cai Sanjun, Director of The Department of Intestinal Surgery of Fudan University, and Director of The Chinese Academy of MedicineShen Lin, chairman of the 3rd MDT China Model Summit Forum and vice president of Peking University Cancer Hospital,
    a win-win situation, MDT promotes double-improvement of doctor-patient benefits
    "This is the best era for China to promote MDT" Zheng Shu, a well-known colorectal cancer expert and professor at Zhejiang University of Medicine, has evaluated the clinical application of MDT (multidisciplinary diagnosis and treatment model).
    MDT is patient-centered and a modern mode of diagnosis and treatment. For an organ or systemic disease, a working group consists of experts from at least two or more disciplines who are fixed, and a working mode of working with a planned and reasonable recommendation for the most scientific diagnosis and treatment for patients through timed and addressed meetings.Shen Lin, vice president of Peking University Cancer Hospital
    , is the promoter, advocate and promoter of Multidisciplinary Comprehensive Treatment of Gastrointestinal Oncology in China, and is also the leader of MDT at Peking University Cancer Hospital. She told reporters that patients who need multidisciplinary treatment, or patients who are controversial in a particular area of treatment, need MDT. And the doctors involved in MDT, in the process of repeated MDT continue to receive treatment information from other disciplines, and constantly summarize the best way to treat the disease, it should be said that for their own "internal forces" to improve, but also benefit endlessly.
    block and long, MDT promotion still has real problems
    " to carry out MDT requires a lot of human and material support. "The Peking University Cancer Hospital has been carrying out MDT in the digestive tract since 2005, and it has been nearly 15 years. As a promoter and promoter, Shen Lin has also long found the real problems in MDT promotion from one practice. Whether doctors have sufficient energy and interest to insist on participating in MDT, at present, domestic medical treatment is still charged by project, the hospital's economic indicators and doctor's income are emphasizing the number of patients treated, whether the hospital can carry out MDT without worrying about income, only to build an MDT team with equal voice, can ensure the continued good operation of MDT, then how to train different echelons of MDT talent?...... These are the problems that China's MDT can't get around in the development and promotion.
    in addition to hospitals and doctors, policy support is also very important for MDT. The National Health and Care Commission has realized the importance of mDT in hospitals and has specifically formulated a column for MDT in the hospital's key disciplines evaluation column. However, the corresponding reasonable charging system has not been established, at present, China's cancer treatment is still charged by project, which to a certain extent limits the development of MDT and the enthusiasm of hospitals and doctors.
    is coming, China's MDT development is in urgent need of a new breakthrough
    for China's MDT development of some difficulties and problems, Shen Lin and many experts at the meeting expressed optimism and confidence.
    ", "First of all, MDT is certainly good for our patients, doctors and hospitals." It helps patients while also improving the professionalism of doctors, while improving the efficiency of hospitals and doctors in treating other patients. This is another perspective on mDT's treatment efficiency - is it also an efficiency manifestation that doctors better diagnose and provide treatment options for patients, while using MDT's accumulated experience to better treat other patients? Shen Lin said that MDT is certainly a very beneficial to the medical treatment of the motherland, worthy of attention, is seriously promoted. Second, MDT's problems in China's development are being improved. Of course, the current domestic MDT operation of the leading power is mostly in hospitals, if hospital leaders can provide good support for MDT, encourage the platform, in terms of operational support, will be more conducive to the development of MDT. At the same time, if the country can establish a corresponding reasonable charging system, it can fundamentally promote the progress of MDT work.Other experts at the
    Forum have also contributed their own recommendations on MDT promotion accumulated in practice. Chen Gong, deputy director of the colorectal department at Sun Yat-sen University Affiliated Oncology Hospital, believes that China's MDT must come up with a standard as soon as possible, and that patients who need MDT should be treated with a standardized MDT, rather than a jagged "team treatment" that has not yet been uniformly evaluated.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.